The novel therapy of this peptide represents a significant development in the management of the condition. Unlike existing drugs, tirzepatide affects multiple pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment